Meningococcal Polysaccharide Vaccine,
Also known as: MENINGITIS A,C,Y, W135
Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is a vaccine for subcutaneous injection. vaccine consists of a sterile lyophilized preparation of the group-specific polysaccharide antigens from N meningitidis, Group A, Group C, Group Y, and Group W-135. N meningitidis are cultivated on Mueller Hinton casein agar and grown in Watson Scherp casamino acid media. The purified polysaccharide is extracted from the N meningitidis cells and separated from the media by procedures which include centrifugation, detergent precipitation, alcohol precipitation, solvent or organic extraction, and diafiltration. No preservative is added during manufacture.
Primary Characteristics
Meningococcal Polysaccharide Vaccine, is also known as MENINGITIS A,C,Y, W135.
It is of Natural origin.
Non-proprietary name: Meningococcal Polysaccharide Vaccine,.
Pharmacokinetics
None recorded.
Advertisement
Indications
Meningococcal Polysaccharide Vaccine, is primarily indicated in conditions like Meningococcal disease.
Contraindications
None recorded.
Dosage
Meningococcal Polysaccharide Vaccine,'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 0.5 ml | 0.5 ml | — | SC | Primary immunization |
| 0.5 ml | 0.5 ml | — | SC | Revaccination |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Meningococcal Polysaccharide Vaccine, is known to cause more or less tolerable side effects which are usually transient. These include Arthralgia, Diarrhoea, Drowsiness, Fatigue, Headache, induration at the injection site, injection site pain, Irritability, Malaise, Pain , Redness.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.19.3.2 — Vaccines for specific groups of individuals